Literature DB >> 22962265

Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo.

Silvestre Vicent1, Leanne C Sayles, Dedeepya Vaka, Purvesh Khatri, Olivier Gevaert, Ron Chen, Yanyan Zheng, Anna K Gillespie, Nicole Clarke, Yue Xu, Joseph Shrager, Chuong D Hoang, Sylvia Plevritis, Atul J Butte, E Alejandro Sweet-Cordero.   

Abstract

Cancer-associated fibroblasts (CAF) have been reported to support tumor progression by a variety of mechanisms. However, their role in the progression of non-small cell lung cancer (NSCLC) remains poorly defined. In addition, the extent to which specific proteins secreted by CAFs contribute directly to tumor growth is unclear. To study the role of CAFs in NSCLCs, a cross-species functional characterization of mouse and human lung CAFs was conducted. CAFs supported the growth of lung cancer cells in vivo by secretion of soluble factors that directly stimulate the growth of tumor cells. Gene expression analysis comparing normal mouse lung fibroblasts and mouse lung CAFs identified multiple genes that correlate with the CAF phenotype. A gene signature of secreted genes upregulated in CAFs was an independent marker of poor survival in patients with NSCLC. This secreted gene signature was upregulated in normal lung fibroblasts after long-term exposure to tumor cells, showing that lung fibroblasts are "educated" by tumor cells to acquire a CAF-like phenotype. Functional studies identified important roles for CLCF1-CNTFR and interleukin (IL)-6-IL-6R signaling in promoting growth of NSCLCs. This study identifies novel soluble factors contributing to the CAF protumorigenic phenotype in NSCLCs and suggests new avenues for the development of therapeutic strategies. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22962265      PMCID: PMC3856949          DOI: 10.1158/0008-5472.CAN-12-1097

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

1.  Global functional profiling of gene expression.

Authors:  Sorin Draghici; Purvesh Khatri; Rui P Martins; G Charles Ostermeier; Stephen A Krawetz
Journal:  Genomics       Date:  2003-02       Impact factor: 5.736

2.  Primary culture of adult mouse lung fibroblasts in serum-free medium: responses to growth factors.

Authors:  R K Kumar; R O'Grady; W Li; L W Smith; G C Rhodes
Journal:  Exp Cell Res       Date:  1991-04       Impact factor: 3.905

3.  Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.

Authors:  Masami Ito; Genichiro Ishii; Kanji Nagai; Ryo Maeda; Yasutaka Nakano; Atsushi Ochiai
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

4.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

5.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

6.  Distinct epigenetic changes in the stromal cells of breast cancers.

Authors:  Min Hu; Jun Yao; Li Cai; Kurt E Bachman; Frédéric van den Brûle; Victor Velculescu; Kornelia Polyak
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

7.  Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.

Authors:  Chun-Peng Liao; Helty Adisetiyo; Mengmeng Liang; Pradip Roy-Burman
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

8.  Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.

Authors:  Elisa Giannoni; Francesca Bianchini; Lorenzo Masieri; Sergio Serni; Eugenio Torre; Lido Calorini; Paola Chiarugi
Journal:  Cancer Res       Date:  2010-08-10       Impact factor: 12.701

9.  Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival.

Authors:  Renate Burger; Frank Bakker; Andreas Guenther; Wolfgang Baum; Dirk Schmidt-Arras; Teru Hideshima; Yu-Tzu Tai; Reshma Shringarpure; Laurence Catley; Giorgio Senaldi; Martin Gramatzki; Kenneth C Anderson
Journal:  Br J Haematol       Date:  2003-12       Impact factor: 6.998

10.  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers.

Authors:  Y Shimosato; A Suzuki; T Hashimoto; Y Nishiwaki; T Kodama; T Yoneyama; T Kameya
Journal:  Am J Surg Pathol       Date:  1980-08       Impact factor: 6.394

View more
  40 in total

1.  Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.

Authors:  Jun W Kim; Cesar P Marquez; R Andres Parra Sperberg; Jiaxiang Wu; Won G Bae; Po-Ssu Huang; E Alejandro Sweet-Cordero; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-10       Impact factor: 11.205

2.  The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.

Authors:  Jeanine L Van Nostrand; Alice Brisac; Stephano S Mello; Suzanne B R Jacobs; Richard Luong; Laura D Attardi
Journal:  Cancer Discov       Date:  2015-03-26       Impact factor: 39.397

3.  Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.

Authors:  Chi Man Tsang; Yuk Chun Cheung; Vivian Wai-Yan Lui; Yim Ling Yip; Guitao Zhang; Victor Weitao Lin; Kenneth Chat-Pan Cheung; Yibin Feng; Sai Wah Tsao
Journal:  BMC Cancer       Date:  2013-12-31       Impact factor: 4.430

4.  Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts.

Authors:  Inga Kretschmer; Till Freudenberger; Sören Twarock; Yu Yamaguchi; Maria Grandoch; Jens W Fischer
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

Review 5.  Caveolae and signalling in cancer.

Authors:  Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Nat Rev Cancer       Date:  2015-04       Impact factor: 60.716

6.  Radiation-hormesis phenotypes, the related mechanisms and implications for disease prevention and therapy.

Authors:  Bobby R Scott
Journal:  J Cell Commun Signal       Date:  2014-10-17       Impact factor: 5.782

7.  α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC).

Authors:  Fengzhou Li; Shilei Zhao; Yanwei Cui; Tao Guo; Jiaqi Qiang; Qiang Xie; Wendan Yu; Wei Guo; Wuguo Deng; Chundong Gu; Taihua Wu
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

Review 8.  Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?

Authors:  Ellen Puré; Albert Lo
Journal:  Cancer Immunol Res       Date:  2016-04       Impact factor: 11.151

9.  Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.

Authors:  Sunitha Kakarla; Kevin K H Chow; Melinda Mata; Donald R Shaffer; Xiao-Tong Song; Meng-Fen Wu; Hao Liu; Lisa L Wang; David R Rowley; Klaus Pfizenmaier; Stephen Gottschalk
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

10.  A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal.

Authors:  Yanyan Zheng; Cecile C de la Cruz; Leanne C Sayles; Chris Alleyne-Chin; Dedeepya Vaka; Tim D Knaak; Marty Bigos; Yue Xu; Chuong D Hoang; Joseph B Shrager; Hans Joerg Fehling; Dorothy French; William Forrest; Zhaoshi Jiang; Richard A D Carano; Kai H Barck; Erica L Jackson; E Alejandro Sweet-Cordero
Journal:  Cancer Cell       Date:  2013-07-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.